Sign in

CIK 0001400118

  • Emerging growth company

Sagimet Biosciences Inc.

Sign in to watch
Ticker
SGMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205991472
Phone
+1 650-561-8600
Business address
950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
Former names
3-V Biosciences, Inc.
  1. 4 Grant or award Chief Financial Officer acquired 44,000 shares (grant or award)
  2. 4 Open-market sale President & CEO sold 12,101 shares at $5.36 ($64,865)
  3. 4 Open-market sale Chief Financial Officer sold 1,312 shares at $5.36 ($7,033)
  4. 4 Open-market sale Chief Medical Officer sold 3,640 shares at $5.36 ($19,511)
  5. 4 Open-market sale Chief Legal & Admin. Officer sold 2,622 shares at $5.36 ($14,054)
  6. 4 Planned sale Executive Chairman sold 37,688 shares at $7.69 ($289,979)
  7. 4 Grant or award Chief Legal & Admin. Officer acquired 9,855 shares (grant or award)
  8. 4 Open-market sale President & CEO sold 65,478 shares at $9.13 ($598,115)
  9. 4 Open-market sale Chief Medical Officer sold 8,277 shares at $9.13 ($75,607)
  10. 4 Open-market sale General Counsel and CCO sold 10,780 shares at $9.13 ($98,471)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Grant or award Chief Medical Officer acquired 34,000 shares (grant or award)
  19. 4 Grant or award President & CEO acquired 116,000 shares (grant or award)
  20. 4 Grant or award General Counsel and CCO acquired 34,000 shares (grant or award)

Page 2 of 5 · 100 filings